Diebold Nixdorf, Incorporated (DBD)
NYSE: DBD · Real-Time Price · USD
53.99
-2.30 (-4.09%)
Aug 1, 2025, 4:00 PM - Market closed
bluebird bio Stock Forecast
Stock Price Forecast
The 2 analysts that cover bluebird bio stock have a consensus rating of "Strong Buy" and an average price target of $65, which forecasts a 20.39% increase in the stock price over the next year. The lowest target is $50 and the highest is $80.
Price Target: $65.00 (+20.39%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2025.
Analyst Ratings
The average analyst rating for bluebird bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Strong Buy Maintains $65 → $80 | Strong Buy | Maintains | $65 → $80 | +48.18% | Feb 27, 2025 |
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | -7.39% | Sep 12, 2024 |
| DA Davidson | DA Davidson | Strong Buy Maintains $55 → $65 | Strong Buy | Maintains | $55 → $65 | +20.39% | Aug 9, 2024 |
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | -7.39% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | -7.39% | Jul 25, 2024 |
Financial Forecast
Revenue This Year
3.83B
from 3.75B
Increased by 2.02%
Revenue Next Year
3.90B
from 3.83B
Increased by 1.96%
EPS This Year
3.55
from -0.44
EPS Next Year
4.68
from 3.55
Increased by 32.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.0B | 4.1B | 4.2B |
| Avg | 3.8B | 3.9B | 4.1B |
| Low | 3.7B | 3.8B | 3.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.7% | 6.3% | 8.3% |
| Avg | 2.0% | 2.0% | 4.2% |
| Low | -1.4% | -1.5% | 1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.75 | 6.05 | 5.30 |
| Avg | 3.55 | 4.68 | 5.10 |
| Low | 3.38 | 3.92 | 4.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 70.6% | 13.2% |
| Avg | - | 32.1% | 8.9% |
| Low | - | 10.6% | 5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.